Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pearlium/Effecti-Cal for Postmenopausal Bone Loss Prevention
NCT04609189Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of Effecti-Cal in postmenopausal osteoporosis, sponsored by University of Alberta. Started Jul 2012; status: completed.
02
Drugs
Effecti-Cal
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT04609189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609189.